Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial

  • Brian G. Feagan
  • , Bruce E. Sands
  • , Corey A. Siegel
  • , Marla C. Dubinsky
  • , Randy S. Longman
  • , João Sabino
  • , Olivier Laurent
  • , Allison Luo
  • , Jiandong Lu
  • , Deanna D. Nguyen
  • , Ernesto J. Muñoz-Elias
  • , Heather Llewellyn
  • , Yong Wang
  • , In Sock Jang
  • , Janine Bilsborough
  • , Ron Marchelletta
  • , Fadi Towfic
  • , Mark Yen
  • , Jaclyn K. Anderson
  • , Aaron DuVall
    • Jaroslaw Kierkus, Marek Woynarowski, Houssam Al Kharrat, Stephan R. Targan, Dermot P.B. McGovern

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science